Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Lee TC et al. Biosynthesis of N-acetylsphingosine by platelet-activating factor: sphingosine CoA-independent transacetylase in HL-60 cels. 1996 J. Biol. Chem. pmid:8550561
Sibelius U et al. Listeriolysin is a potent inducer of the phosphatidylinositol response and lipid mediator generation in human endothelial cells. 1996 Infect. Immun. pmid:8550226
Meijer F et al. Nitric oxide induces vascular permeability changes in the guinea pig conjunctiva. 1995 Eur. J. Pharmacol. pmid:8549637
Evangelou A et al. Inhibition of PAF-acether effects on isolated guinea pig hearts by zinc ions (Zn2+). 1995 Biol Trace Elem Res pmid:8546883
Rubio de Krömer MT et al. Differences in eosinophil and neutrophil chemotactic responses in sowda and generalized form of onchocerciasis. 1995 Acta Trop. pmid:8546035
Furukawa M et al. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions. 1995 Laryngoscope pmid:8544602
Naraba H et al. Activation of phospholipase A2 and acylation of lysophospholipids: the major regulators for platelet activating factor production in rat neutrophils. 1995 J. Biochem. pmid:8543583
Abu-Zidan FM et al. Role of platelet-activating factor antagonism in haemorrhagic shock in pigs. 1995 Eur Surg Res pmid:8542923
Izumi T and Shimizu T Platelet-activating factor receptor: gene expression and signal transduction. 1995 Biochim. Biophys. Acta pmid:8541341
Siminiak T et al. Plasma mediated neutrophil stimulation during coronary angioplasty: autocrine effect of platelet activating factor. 1995 Br Heart J pmid:8541167
Cluzel J et al. Inhibition of platelet-activating factor-induced retinal impairments by cholera and pertussis toxins. 1995 Ophthalmic Res. pmid:8538992
Ramírez MM et al. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. 1995 Microvasc. Res. pmid:8538502
Schwappach JR et al. Superoxide dismutase attenuates effects of platelet-activating factor on gastric microcirculation. 1995 J. Surg. Res. pmid:8538173
Guimbaud R et al. Intraluminal excretion of PAF, lysoPAF, and acetylhydrolase in patients with ulcerative colitis. 1995 Dig. Dis. Sci. pmid:8536524
Bustos C et al. Cyclosporin A (CsA) modulates the glomerular production of inflammatory mediators and proteoglycans in experimental nephrosis. 1995 Clin. Exp. Immunol. pmid:8536380
Schmid E et al. Signaling by E-selectin and ICAM-1 induces endothelial tissue factor production via autocrine secretion of platelet-activating factor and tumor necrosis factor alpha. 1995 J. Interferon Cytokine Res. pmid:8536111
Giessler C et al. Effects of PAF on cardiac function and eicosanoid release in the isolated perfused rat heart: comparison between normotensive and spontaneously hypertensive rats. 1995 Jul-Aug Basic Res. Cardiol. pmid:8534259
Kirejczyk JK et al. Oxygen-derived free radicals in kidney in experimental hemorrhagic shock treated by PAF-receptor antagonist BN 52021. 1995 Rocz. Akad. Med. Bialymst. pmid:8528997
Kirejczyk JK et al. Ginkgolide BN 52021 protects against hemorrhagic shock-induced renal injury in rats. 1995 Rocz. Akad. Med. Bialymst. pmid:8528996
Debek W et al. Luminol-chemiluminescence in free peritoneal cells in hemorrhagic shock in rats treated with PAF-receptor-antagonist BN 52021. 1995 Rocz. Akad. Med. Bialymst. pmid:8528982
Ahmed A et al. Oestradiol-17 beta modulates PAF-evoked phospholipase D activity but not inositide-lipid hydrolysis in human endometrial cell line, HEC-1B. 1995 Cell. Signal. pmid:8527309
Oshiro H et al. L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo. 1995 J. Vasc. Surg. pmid:8523608
Noel AA et al. Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation. 1995 J. Vasc. Surg. pmid:8523600
Nishida K et al. Increased brain levels of platelet-activating factor in a murine acquired immune deficiency syndrome are NMDA receptor-mediated. 1996 J. Neurochem. pmid:8522986
Diserbo M et al. Stimulation of platelet-activating factor (PAF) receptors increases inositol phosphate production and cytosolic free Ca2+ concentrations in N1E-115 neuroblastoma cells. 1995 Cell Calcium pmid:8521458
Nishi O et al. Effects of platelet activating factor on mouse embryo implantation in vitro. 1995 J. Assist. Reprod. Genet. pmid:8520198
Okano S et al. Effect of platelet activating factor antagonist (TCV-309) on lung injury in dogs with experimentally endotoxin-induced shock. 1995 J. Vet. Med. Sci. pmid:8519912
Amorim CZ et al. Involvement of platelet-activating factor in death following anaphylactic shock in boosted and in unboosted mice. 1993 Eur. J. Pharmacol. pmid:8519279
Kawahara K et al. The effect of the platelet-activating factor inhibitor TCV-309 on reperfusion injury in a canine model of ischemic lung. 1993 Transplantation pmid:8516834
Nishiyama R et al. Platelet-activating factor in hepatic ischemia/reperfusion injury. The effects of a PAF antagonist combined with a prostaglandin I2 analogue. 1993 Transplantation pmid:8516812
Rabinovici R et al. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. 1993 J. Appl. Physiol. pmid:8514698
Koyama N et al. Increased platelet activating factor in the tracheal aspirates from neonates with patent ductus arteriosus. 1993 Clin. Chim. Acta pmid:8513570
Dell' Albani P et al. Platelet-activating factor and its methoxy-analogue ET-18-OCH3 stimulate immediate early gene expression in rat astroglial cultures. 1993 Neurochem. Int. pmid:8513284
Warringa RA et al. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. 1993 J. Allergy Clin. Immunol. pmid:8509580
van den Bosch H et al. Ether lipid synthesis and its deficiency in peroxisomal disorders. 1993 Biochimie pmid:8507680
Ono I et al. Effects of a platelet activating factor antagonist on oedema formation following burns. 1993 Burns pmid:8507364
Tsukioka K et al. [Increased plasma levels of platelet-activating factor (PAF) and low serum PAF acetylhydrolase (PAFAH) activity in adult patients with bronchial asthma]. 1993 Arerugi pmid:8507159
Misawa M and Sugiyama Y An airway hyperresponsiveness model in rat allergic asthma. 1993 Arerugi pmid:8507151
Sirén AL et al. Increased release of tumor necrosis factor-alpha into the cerebrospinal fluid and peripheral circulation of aged rats. 1993 Stroke pmid:8506560
Davis TM et al. Platelet-activating factor and lipid metabolism in acute malaria. 1993 J. Infect. pmid:8505562
Ferraris L et al. Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis. 1993 Gut pmid:8504968
Baldi E et al. Stimulation of platelet-activating factor synthesis by progesterone and A23187 in human spermatozoa. 1993 Biochem. J. pmid:8503848
Sun DX et al. Platelet activating factor production in bovine cerebral microvascular endothelial cells and its drug inhibition. 1993 Zhongguo Yao Li Xue Bao pmid:8503282
Pfliegler G et al. Sodium fluoride induced activation of phospholipase C in intact human platelets does not depend on ADP, PAF or arachidonate products. 1993 Thromb. Res. pmid:8503122
Inoue H et al. Study on the metabolism of lyso-platelet activating factor (lyso-PAF) in human paranasal sinus mucosa. The cultured ciliated epithelium can convert lyso-PAF to PAF. 1993 Life Sci. pmid:8502110
Chu M et al. A novel class of platelet activating factor antagonists from Phoma sp. 1993 J. Antibiot. pmid:8500998
Roudebush WE et al. Enhanced embryo development of rabbit oocytes fertilized in vitro with platelet activating factor (PAF)-treated spermatozoa. 1993 J. Assist. Reprod. Genet. pmid:8499686
Wilson DV and Stick JA Effect of a specific platelet-activating factor antagonist on cardiovascular and peripheral cellular responses to colonic ischemia and reperfusion in anesthetized ponies. 1993 Am. J. Vet. Res. pmid:8498751
Shibamoto T et al. PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs. 1993 Am. J. Physiol. pmid:8498559
Miura S et al. Attenuation of endotoxin-induced intestinal microcirculatory damage by eicosapentanoic acid. 1993 Am. J. Physiol. pmid:8498509
Trova MP et al. Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring. 1993 J. Med. Chem. pmid:8496938
Jarvi K et al. Effect of platelet-activating factor, lyso-platelet-activating factor, and lysophosphatidylcholine on sperm motion: importance of albumin for motility stimulation. 1993 Fertil. Steril. pmid:8495776
Pons F et al. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505. 1993 Br. J. Pharmacol. pmid:8495241
Nathan N and Denizot Y Tumor necrosis factor and platelet-activating factor during cardiopulmonary bypass. 1993 Ann. Thorac. Surg. pmid:8494455
Zhou W et al. Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation. 1993 Am. J. Pathol. pmid:8494049
Alabaster VA and Moore BA New perspectives on basic mechanisms in lung disease. 3. Drug intervention in asthma: present and future. 1993 Thorax pmid:8493636
Wagner G et al. [Synthesis of N-(2-carboxy-thieno(2,3-b)pyridin-3-yl)-formamidines corresponding alkyl esters with antianaphylactic activity]. 1993 Pharmazie pmid:8493283
Fukuda T [The eosinophil and bronchial asthma]. 1993 Nippon Rinsho pmid:8492453
Iwahisa Y et al. [Advance in eosinophil chemotaxis assay method--automatic count of migrated cells by the image analyzing system in the Boyden method]. 1993 Nippon Rinsho pmid:8492448
Kawada I and Takahashi K [A new method for the isolation of peripheral blood eosinophils using flow cytometry (FCM)]. 1993 Nippon Rinsho pmid:8492447
Cipolle MD et al. Secondary organ dysfunction. From clinical perspectives to molecular mediators. 1993 Crit Care Clin pmid:8490763
Sablina MA et al. [Synthesis of platelet activation factor analogs]. 1993 Bioorg. Khim. pmid:8489534
Lekka M et al. Isolation of a phospholipid inhibitor of platelet activating factor-induced activity from perfused rat liver: identification as phosphatidylglycerol. 1993 Arch. Biochem. Biophys. pmid:8489242
Steinke B et al. [Biological standardization of Ginkgo extracts]. 1993 Planta Med. pmid:8488195
Barthelson RA Quantitation of IL-4 expression in small numbers of cells from mice. 1993 J. Immunol. Methods pmid:8486929
Catalán RE et al. Platelet-activating factor stimulates protein kinase C translocation in cerebral microvessels. 1993 Biochem. Biophys. Res. Commun. pmid:8484756
Lohman IC and Halonen M The effects of combined histamine and platelet-activating factor antagonism on systemic anaphylaxis induced by immunoglobulin E in the rabbit. 1993 Am. Rev. Respir. Dis. pmid:8484635
Yamanaka S et al. 11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs. 1993 Prostaglandins pmid:8484010
van der Bruggen T et al. Cytokine priming of the respiratory burst in human eosinophils is Ca2+ independent and accompanied by induction of tyrosine kinase activity. 1993 J. Leukoc. Biol. pmid:8482914
Sakamoto T et al. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig. 1993 J. Appl. Physiol. pmid:8482649
Kiyohara T et al. Effect of endothelin 1 on ion transport in isolated rat colon. 1993 Gastroenterology pmid:8482447
Kroegel C et al. Ultrastructural characterization of platelet-activating factor-stimulated human eosinophils from patients with asthma. 1993 Clin. Sci. pmid:8482044
Koenderman L et al. Granulocyte-macrophage colony-stimulating factor induces sequential activation and deactivation of binding via a low-affinity IgG Fc receptor, hFc gamma RII, on human eosinophils. 1993 Blood pmid:8481520
Hebra A et al. Systemic and mesenteric vascular effects of platelet-activating factor and cocaine. In vivo effects on a neonatal swine model. 1993 Am Surg pmid:8480932
Murphy G Report of the 14th meeting of the British Inflammation Research Association. Topic: cellular and molecular aspects of inflammatory bowel disease. 1993 Agents Actions pmid:8480529
Ranaut K and Singh M BN-50739: a PAF antagonist and limitation of myocardial infarct size. 1993 Jan-Feb Methods Find Exp Clin Pharmacol pmid:8479250
Lamouri A et al. Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2-[[(substituted carbonyl and carbamoyl)oxy]methyl]piperazines. 1993 J. Med. Chem. pmid:8478911
Walker TS and Mellott GE Rickettsial stimulation of endothelial platelet-activating factor synthesis. 1993 Infect. Immun. pmid:8478089
Makristathis A et al. Bacteria induce release of platelet-activating factor (PAF) from polymorphonuclear neutrophil granulocytes: possible role for PAF in pathogenesis of experimentally induced bacterial pneumonia. 1993 Infect. Immun. pmid:8478087
Björck T and Dahlén SE Leukotrienes and histamine mediate IgE-dependent contractions of human bronchi: pharmacological evidence obtained with tissues from asthmatic and non-asthmatic subjects. 1993 Pulm Pharmacol pmid:8477156
Minhas BS Platelet-activating factor treatment of human spermatozoa enhances fertilization potential. 1993 Am. J. Obstet. Gynecol. pmid:8475981
Inui K [Participation of platelet activating factor in the pulmonary injury during cardiopulmonary bypass]. 1993 Nihon Kyobu Geka Gakkai Zasshi pmid:8473789
Juncos LA et al. Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products. 1993 J. Clin. Invest. pmid:8473488
Kroegel C and Matthys H Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics. 1993 Immunology pmid:8473016
Taylor ML et al. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects. 1993 Br J Clin Pharmacol pmid:8471399
Sandberg-Gertzén H An open trial of Cedemin, a Gingko biloba extract with PAF-antagonistic effects for ulcerative colitis. 1993 Am. J. Gastroenterol. pmid:8470656
Fukuoka T et al. Platelet activating factor mediates systemic circulatory collapse after temporary hepatic inflow occlusion. 1993 Transplant. Proc. pmid:8470175
Tetta C et al. Role of platelet activating factor in hemodialysis. 1993 Kidney Int. Suppl. pmid:8468919
Shikano M et al. Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1. 1993 J. Immunol. pmid:8468486
Wong CW et al. Comparative effects of tetrandrine and berbamine on guineapig airway microvascular leakage induced by platelet-activating factor and other allergic mediators. 1993 Int. J. Immunopharmacol. pmid:8468119
McCafferty DM et al. Inhibition of platelet-activating factor-induced leukocyte adhesion in vivo by a leumedin. 1993 Eur. J. Pharmacol. pmid:8467855
Ono S et al. Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC. 1993 Surg. Today pmid:8467174
Korth R et al. Human platelets release a paf-acether: acetylhydrolase similar to that in plasma. 1993 Lipids pmid:8464350
Nagai H et al. Priming with murine recombinant interleukin-5 resulted in the augmentation of PAF-induced airway hyperresponsiveness to histamine in guinea pigs. 1993 Life Sci. pmid:8464339
Battye KM et al. Potential synergism between platelet-activating factor and alpha 1-recombinant interferon in promoting luteal maintenance in cyclic ewes. 1993 J. Reprod. Fertil. pmid:8464013
Venable ME et al. Enzymatic studies of lyso platelet-activating factor acylation in human neutrophils and changes upon stimulation. 1993 J. Biol. Chem. pmid:8463317
Wieraszko A et al. Long-term potentiation in the hippocampus induced by platelet-activating factor. 1993 Neuron pmid:8461142
Olson NC et al. Pertussis toxin attenuates platelet-activating factor-induced pulmonary hemodynamic alterations in pigs. 1993 Am. J. Physiol. pmid:8460710
Kertscher HP et al. [PAF-antagonists with a phospholipid structure. 5. Propanediol phospholipids with various substituted pyridinium and quinuclidinium head groups and variations of the phosphorus-nitrogen distance;synthesis, characterization and structure activity relationship]. 1993 Pharmazie pmid:8460172
Kosugi T et al. Inhalation of platelet-activating factor increases respiratory resistance in rats: determination by means of an astograph under nonanesthetized conditions. 1993 Laryngoscope pmid:8459752